Sakuranetin ameliorates experimental colitis in a gut microbiota-dependent manner
- 17 February 2025
- journal article
- Published by Elsevier in Phytomedicine
- Vol. 139, 156540
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82070561)
- National Natural Science Foundation of China (82370534)
This publication has 62 references indexed in Scilit:
- Sakuranetin reduces inflammation and chondrocyte dysfunction in osteoarthritis by inhibiting the PI3K/AKT/NF-κB pathwayBiomedicine & Pharmacotherapy, 2024
- Ento-A alleviates DSS-induced experimental colitis in mice by remolding intestinal microbiota to regulate SCFAs metabolism and the Th17 signaling pathwayBiomedicine & Pharmacotherapy, 2023
- Polysaccharides from Tetrastigma Hemsleyanum Diels et Gilg ameliorated inflammatory bowel disease by rebuilding the intestinal mucosal barrier and inhibiting inflammation through the SCFA-GPR41/43 signaling pathwayInternational Journal of Biological Macromolecules, 2023
- ADT-OH improves intestinal barrier function and remodels the gut microbiota in DSS-induced colitisFrontiers of Medicine, 2023
- Distinctive anti-inflammatory effects of resveratrol, dihydroresveratrol, and 3-(4-hydroxyphenyl)-propionic acid on DSS-induced colitis in pseudo-germ-free miceFood Chemistry, 2022
- Jiangu granule ameliorated OVX rats bone loss by modulating gut microbiota-SCFAs-Treg/Th17 axisBiomedicine & Pharmacotherapy, 2022
- Crataegus pinnatifida polysaccharide alleviates colitis via modulation of gut microbiota and SCFAs metabolismInternational Journal of Biological Macromolecules, 2021
- Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?EBioMedicine, 2021
- Valeric acid lowers arterial blood pressure in ratsEuropean Journal of Pharmacology, 2020
- Bacteroides-Derived Sphingolipids Are Critical for Maintaining Intestinal Homeostasis and SymbiosisCell Host & Microbe, 2019